Jeff Yass’s SteadyMed Ltd STDY Stock Holding History

Jeff Yass’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-33,245	Closed	-$113K	–	10301
2017 Q3	$113K	Sell	33,245 -165,355	-83%	-$880K	﹤0.01%	8316
2017 Q2	$1.25M	Buy	+198,600	New	+$1.35M	﹤0.01%	4806

Other funds holding STDY

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Jeff Yass's STDY Position: Q4 2017 in Review

Jeff Yass sold out of SteadyMed Ltd (STDY) in Q4 2017, closing a stake of 33,245 shares — an estimated $113K sold.

Jeff Yass first reported a position in STDY in Q2 2017 and held it in 2 quarters. The position peaked at $1.25M in Q2 2017. 27 funds tracked by Wall St. Rank hold STDY as of Q4 2017.

Jeff Yass reported no remaining SteadyMed Ltd position as of Q4 2017 after selling out during the quarter.
Jeff Yass sold 33,245 SteadyMed Ltd shares in Q4 2017, an estimated $113K.
Jeff Yass first reported a position in SteadyMed Ltd in Q2 2017 and held it in 2 quarters.
Jeff Yass's SteadyMed Ltd position peaked at $1.25M in Q2 2017.
27 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q4 2017.

Based on Susquehanna International Group's 13F filing for Q4 2017, filed 14 Feb 2018.